Transcripts
Relmada Therapeutics (RLMD) earnings call transcripts
Earnings call transcripts for Relmada Therapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed the quarter as an execution phase, with manufacturing the remaining gate to IND filing and registration-enabling trials.
Aug 06, 2026Positive0.48